Corcept Therapeutics | CORT - 股票



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.92B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


股票 更改 日
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
ANI Pharmaceuticals USD 143.15M 319K 2026-06
Ardelyx USD 128.02M 110.29M 2026-03
Aurora Cannabis CAD 175.08M 55.48M 2026-03
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Canopy Growth CAD 110.51M 4.96M 2026-03
Corcept Therapeutics USD 13.18M 295K 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
J&J USD 15.14B 561M 2026-06
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Lexicon Pharmaceuticals USD 276K 5K 2026-03
Merck USD 6.21B 272M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.22B 66M 2026-06
Novartis USD 6.29B 135M 2026-03
Omeros USD 712K 266K 2021-09
Pacira USD 134.57M 15.8M 2026-06
Pfizer USD 9.94B 722M 2026-06
Supernus Pharmaceuticals USD 107.03M 3.74M 2026-06
TG Therapeutics USD 147.97M 18.94M 2026-06